The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Rheumatoid factor (RF) levels above a normal range can indicate autoimmune conditions, such as rheumatoid arthritis (RA). Rheumatoid factor (RF) is an immune system protein that attacks healthy ...

Swimming can help relieve the joint pain and stiffness you may experience with rheumatoid arthritis (RA). It can also help protect your joints through strengthening your muscles. The America Heart ...

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

The FDA has approved Celltrion’s similar of Genentech’s Actemra (tocilizumab). Celltrion’s Avtozma (tocilizumab-anoh) will be available as both an intravenous (IV) and subcutaneous (SC) formulations ...

Background: Immunotherapy targeting factors related to immune imbalance has been widely employed for RA treatment. This study aimed to evaluate the efficacy and safety of low-dose interleukin (IL)-2 ...

China Objectives To investigate the effectiveness and safety of TCZ (tocilizumab) monotherapy for chronic periaortitis (CP) patients at acute active stage. Methods Twelve patients with definite or ...

Tocilizumab (TCZ), an anti-interleukin (IL)-6 receptor antagonist approved for the treatment of inflammatory diseases, such as rheumatoid arthritis and giant cell arteritis, may be useful in managing ...

Elevated levels of interleukin-6 (IL-6), a proinflammatory cytokine, has been associated with GCA. Tocilizumab (TCZ), a humanised antihuman IL-6 receptor antibody, has been used successfully in ...